Healthcare & Life Sciences

Novadip Biosciences

series-b
series-b
Stage
1
Investors

About

Novadip Biosciences is a regenerative medicine spin-off founded in 2013 from UCLouvain and affiliated clinics by Drs Denis Dufrane and Jean‑François Pollet. The company develops regenerative medicine/biotech therapies.

Explore Novadip Biosciences's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.